Compare BRCC & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRCC | CGTX |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 186.6M | 158.8M |
| IPO Year | N/A | 2021 |
| Metric | BRCC | CGTX |
|---|---|---|
| Price | $1.24 | $1.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | $2.63 | ★ $2.88 |
| AVG Volume (30 Days) | 541.2K | ★ 942.9K |
| Earning Date | 11-03-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $391,401,000.00 | N/A |
| Revenue This Year | $3.12 | N/A |
| Revenue Next Year | $11.04 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.17 | $0.22 |
| 52 Week High | $3.34 | $3.83 |
| Indicator | BRCC | CGTX |
|---|---|---|
| Relative Strength Index (RSI) | 45.95 | 53.10 |
| Support Level | $1.22 | $1.69 |
| Resistance Level | $1.28 | $1.77 |
| Average True Range (ATR) | 0.05 | 0.12 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 43.33 | 75.58 |
BRC Inc is a veteran-controlled company that serves premium coffee, content, and merchandise to active military, veterans, and first responders. It is committed to producing great coffee that consumers love, and high-quality merchandise that enables its community to showcase its brand. Its omnichannel distribution has three components: Direct to Consumer channel includes its e-commerce business, through which consumers order products online and products are shipped to them, Its wholesale channel includes products sold to an intermediary such as convenience, grocery, drug, and mass merchandise stores, who in turn sell those products to consumers, and Outpost channel includes revenue from its Company-operated and franchised Black Rifle Coffee retail coffee shop locations.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.